InvestorsHub Logo
Followers 467
Posts 26912
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 7

Friday, 10/21/2011 11:16:00 AM

Friday, October 21, 2011 11:16:00 AM

Post# of 56
6. Codexis, Inc. (CDXS): Develops proprietary biocatalysts for pharmaceuticals and biofuels markets. Market cap of $159.0M. Estimated EPS growth over the next 5 years at 25.0%. Net institutional shares purchased over the current quarter at 1.3M, which is 6.21% of the company's 20.92M share float. The stock is a short squeeze candidate, with a short float at 7.02% (equivalent to 8.76 days of average volume). The stock is currently stuck in a downtrend, trading 6.54% below its SMA20, 22.5% below its SMA50, and 50.94% below its SMA200. The stock has performed poorly over the last month, losing 13.54%.

http://seekingalpha.com/article/299037-8-high-growth-biotech-stocks-being-bought-by-hedge-funds?source=yahoo


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDXS News